Brief: Acrux Sees Regulatory Approval For Two Of Topical Generic Products This Year
23/11/2022 01:03
Nov 23 (Reuters) - Acrux ACR.AX :
* EXPECTS TO RECEIVE REGULATORY APPROVAL FOR TWO OF ITS
TOPICAL
GENERIC PRODUCTS THIS FINANCIAL YEAR
Source text for Eikon: ID:nASX7wqHfF
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share